Evaluation Of the, Galantamine and Memantine co-administration on the Cognitive Deficits
Not Applicable
- Conditions
- Cognition disorder due to Electro Convalsive Therapy.Degenerative disease of nervous system, unspecified
- Registration Number
- IRCT2015051720913N1
- Lead Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Inclusion critria: Aged between 60-18 years- the number of ECT sessions between 6 and 12- live in the city of Ahvaz. Exclusion criteria: alcohol and drug dependency orabuse during the 3 months prior to admission (except nicotine or caffeine)- diseases of the ducumented (kidney fixed Renal Failure)- epilepsy- Mental Retardation based on clinical assessment and evaluation by phicisian(resident)- delirium- dementia and cognitive disorders- pregnancy and breast feeding-use of memantine and galantamine than 3 months prior to admission- patients receiving thiazide diuretics- ducumented history and drug sensitivity effects with memantine and galantamine .
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Galantamine-Memantine-ECT numbers-MMSE Test score. Timepoint: One day before and one day after Electro Convalsive Therapy. Method of measurement: Questionary scors MMSE-Questionary Digit Span of Wechsler.
- Secondary Outcome Measures
Name Time Method